
Keywords: مورفومتری مبتنی بر تانسور; AD; Alzheimer's disease; MCI; mild cognitive impairment; MRI; magnetic resonance imaging; FDG; fluorodeoxyglucose; PET; positron emission topography; FDA; Food and Drug Administration; NIA; National Institute of Aging; AA; Alzheimer's Association; IWG; In